Similar Papers

Paper Title
Journal
Date
Author
National Comprehensive Cancer Network Guidelines: Who Makes Them? What Are They? Why Are They Important?
Lenora A Pluchino ... Thomas A D’Amico
The Annals of Thoracic Surgery | VOL. 110
Lenora A Pluchino, et. al.Lenora A Pluchino ... Thomas A D’Amico
13 Apr 2020
Scores and Misses With New Technology—Walking the Narrow Path of Evidence
Sushil Beriwal ... Ann H Klopp
International Journal of Radiation Oncology, Biology, Physics | VOL. 105
Sushil Beriwal, et. al.Sushil Beriwal ... Ann H Klopp
04 Sep 2019
Second-line treatment options in metastatic castration-resistant prostate cancer: A comparison of key trials with recently approved agents
Amit Bahl ... Johann De Bono
Cancer Treatment Reviews | VOL. 40
Amit Bahl, et. al.Amit Bahl ... Johann De Bono
16 Aug 2013
430 Real-world outcomes of patients with resected stage IIIA melanoma treated with adjuvant nivolumab in a US community setting
Wolfram Samlowski ... Jennell Palaia
Journal for ImmunoTherapy of Cancer | VOL. 10
Wolfram Samlowski, et. al.Wolfram Samlowski ... Jennell Palaia
01 Nov 2022
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing
Janis M Taube ... Carlo B Bifulco
Journal for ImmunoTherapy of Cancer | VOL. 13
Janis M Taube, et. al.Janis M Taube ... Carlo B Bifulco
08 Jan 2025
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
Daniela Esposito ... Luigi Formisano
Journal for ImmunoTherapy of Cancer | VOL. 13
Daniela Esposito, et. al.Daniela Esposito ... Luigi Formisano
01 Jan 2025
CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors
Yi Sun ... Yuwen Zhu
Journal for ImmunoTherapy of Cancer | VOL. 13
Yi Sun, et. al.Yi Sun ... Yuwen Zhu
01 Jan 2025
Weal and woe of interleukin-18 in the T cell therapy of cancer
Christoph Kessel ... Hinrich Abken
Journal for ImmunoTherapy of Cancer | VOL. 13
Christoph Kessel, et. al.Christoph Kessel ... Hinrich Abken
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.